Publications

• Human African trypanosomiasis. Büscher P, Cecchi G, Jamonneau V, Priotto G. The Lancet, Nov 2017, Vol. 390, pp. 2397–2409
• Sleeping Sickness.  Malvy D, Chappuis F. Clinical Microbiology and Infection, July 2011, Vol. 17, pp. 986–995
• Human African trypanosomiasisexternal icon.  Brun R, Blum, J, Chappuis F, Burri C. The Lancet, January 9, 2010, Vol. 375, pp. 148–159

Back To Top

• Tsetse Flies (Glossina) as Vectors of Human African Trypanosomiasis: A Review.  Florence Njeri Wamwiri and Robert Emojong Changasi. BioMed Research International. 2016. http://dx.doi.org/10.1155/2016/6201350external icon
• The journey towards elimination of gambiense human African trypanosomiasis: not far, nor easy. Franco JR, Simarro PP, Diarra A, Ruiz-Postigo JA, Jannin JG. Parasitology. 2014;141(6):748–760.
• The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000–2009: the way forwardexternal icon.  Simarro PP, Diarra A, Ruiz Postigo JA, Franco JR, Jannin JG. PLoS Neglected Tropical Diseases, February 2011, Vol. 5(2)
• The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseasesexternal icon.  Simarro PP, Cecch G, Paone M, et al. International Journal of Health Geographics, 2010, Vol. 9:57

Back To Top

• Control and surveillance of human African trypanosomiasis: report of a WHO expert committee; 2013. https://apps.who.int/iris/handle/10665/95732external icon Human African trypanosomiasis in non-endemic countries (2000–2010)external icon.  Simarro PP, Franco JR, Cecchi G, et al. Journal of Travel Medicine, January–February 2012, Vol. 19(1)
• Multiorgan dysfunction caused by travel-associated African trypanosomiasis.  Lucy E. Cottle, Joanna R. Peters, Alison Hall, J. Wendi Bailey, Harry A. Noyes, Jane E. Rimington, Nicholas J. Beeching, S. Bertel Squire, Mike B.J. Beadsworth. Emerging Infectious Diseases, February 2012, Vol. 18(2), pp. 287–289
• Safety and efficacy of the 10-day melarsoprol schedule for the treatment of second stage Rhodesiense sleeping sickness. Kuepfer I, Schmid C, Allan M, Edielu A, Haary EP, Kakembo A, Kibona S, Blum J, Burri C. PLoS Negl Trop Dis. 2012 Aug;6(8)Sleeping sickness in travelers – do they really sleep?external icon  Urech K, Neumayr A, Blum J. PLoS Neglected Tropical Diseases, November 2011, Vol.5(11)
• Lethal African trypanosomiasis in a traveler: MRI and neuropathologyexternal icon.  Braakman HM, van de Molengraft, FJ, Hubert WW, Boerman DH. Neurology, April 2006, Vol. 66(7)
• Clinical aspects of 2541 patients with second stage human African trypanosomiasisexternal icon.  Blum J, Schmid C, Burri C. Acta Tropica, January 2006, Vol. 97(1)
• Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II). Schmid C, Richer M, Bilenge CM, Josenando T, Chappuis F, Manthelot CR, Nangouma A, Doua F, Asumu PN, Simarro PP, Burri C. J Infect Dis. 2005 Jun 1;191(11):1922–31
• Case records of the Massachusetts General Hospital. Weekly clinicopathological exercisesexternal icon. Moore AC, Ryan ET, Waldron MA. New England Journal of Medicine, March 2004, Vol. 350(12)
• Efficacy of 10-day melarsoprol schedule 2 years after treatment for late-stage gambiense sleeping sickness. Schmid C, Nkunku S, Merolle A, Vounatsou P, Burri C.  Lancet 2004; 364:789–90
• Cluster of African trypanosomiasis in travelers to Tanzanian national parks.  Jelinek T, Bisoffi Z, Bonazzi L, et al. Emerging Infectious Diseases, June 2002, Vol. 8(6)

Back To Top